Coatings specialist joins Bayer MaterialScience

Steven Sternberger takes industrial marketing manager role

Bayer MaterialScience has appointed Steven Sternberger as industrial marketing manager for coatings in the Coatings, Adhesives and Specialties (CAS) business unit.

In this role, Sternberger will lead the CAS team’s efforts to meet evolving coatings requirements for industrial customers.

Prior to joining Bayer, Sternberger was the director of marketing for industrial coatings at PPG Industries. He has 30 years’ marketing and sales experience in many segments of the coatings industry.

You may also like

Manufacturing

ProBioGen chosen to lead GMP manufacturing operations at Berlin Center for Gene and Cell Therapies

The company will oversee the design, lead the construction and subsequently operate the 4600-square-meter GMP manufacturing unit
Dosage Forms

Bayer Aspirin introduces Aspirina to the US pain market

Bayer Aspirin has provided families with fast pain relief for generations and is continuing the tradition of health and pain relief by launching Aspirina, a product familiar to the US Hispanic community
Manufacturing

Shift log management solution enhances shop floor efficiency at Bayer

Bayer AG's drug substance finishing plant in Charlottenburg, Germany, has adopted eschbach's Shiftconnector platform to streamline shop floor communication, eliminate inefficiencies and enhance operational excellence with real-time visibility and integrated workflows
Research & Development

LIfT BioSciences licenses Bayer's Cambridge lab facilities to advance oncology research

LIfT will use Bayer's Co.Lab facilities to advance its immuno-modulatory alpha neutrophil platform for the mitigation of treatment resistance in solid tumours
Regulatory

Bayer's acoramidis recommended for approval by the EMA's CHMP for cardiomyopathy

The orally administered transthyretin (TTR) stabiliser is suitable for patients with transthyretin amyloid cardiomyopathy, demonstrating at least a 90% TTR stabilisation capacity and a reduction in cardiovascular-related hospitalisations
Distribution

PanTera signs agreement with Bayer for the supply of actinium-225

The company will provide 225Ac for clinical trial needs
Research & Development

Recursion adds new chemical entity targeting fibrotic diseases to late discovery pipeline

Potential first-in-class molecule with novel target inlicensed from collaboration with Bayer
Subscribe now